Compile Data Set for Download or QSAR
Report error Found 71 Enz. Inhib. hit(s) with all data for entry = 10473
TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538202(US11253521, No. 72)
Affinity DataIC50: 5.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538208(US11253521, No. 78)
Affinity DataIC50: 6.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538201(US11253521, No. 71)
Affinity DataIC50: 6.70nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538203(US11253521, No. 73)
Affinity DataIC50: 7.60nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538207(US11253521, No. 77)
Affinity DataIC50: 8.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538204(US11253521, No. 74)
Affinity DataIC50: 8.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538178(US11253521, No. 48)
Affinity DataIC50: 9.30nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538196(US11253521, No. 66)
Affinity DataIC50: 9.30nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538210(US11253521, No. 80)
Affinity DataIC50: 9.40nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538206(US11253521, No. 76)
Affinity DataIC50: 9.40nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538200(US11253521, No. 70)
Affinity DataIC50: 9.80nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538173(US11253521, No. 43)
Affinity DataIC50: 9.90nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538199(US11253521, No. 69)
Affinity DataIC50: 10nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538174(US11253521, No. 44)
Affinity DataIC50: 10.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538153(US11253521, No. 23)
Affinity DataIC50: 11nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538180(US11253521, No. 50)
Affinity DataIC50: 11.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538205(US11253521, No. 75)
Affinity DataIC50: 11.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538187(US11253521, No. 57)
Affinity DataIC50: 12.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538188(US11253521, No. 58)
Affinity DataIC50: 12.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538176(US11253521, No. 46)
Affinity DataIC50: 12.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538171(US11253521, No. 41)
Affinity DataIC50: 13.3nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538183(US11253521, No. 53)
Affinity DataIC50: 13.7nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538175(US11253521, No. 45)
Affinity DataIC50: 14nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538189(US11253521, No. 59)
Affinity DataIC50: 14.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538162(US11253521, No. 32)
Affinity DataIC50: 14.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538186(US11253521, No. 56)
Affinity DataIC50: 14.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538194(US11253521, No. 64)
Affinity DataIC50: 14.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538170(US11253521, No. 40)
Affinity DataIC50: 15.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538177(US11253521, No. 47)
Affinity DataIC50: 15.7nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538190(US11253521, No. 60)
Affinity DataIC50: 16nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538185(US11253521, No. 55)
Affinity DataIC50: 16.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538172(US11253521, No. 42)
Affinity DataIC50: 16.5nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538209(US11253521, No. 79)
Affinity DataIC50: 16.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538191(US11253521, No. 61)
Affinity DataIC50: 16.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538193(US11253521, No. 63)
Affinity DataIC50: 16.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538195(US11253521, No. 65)
Affinity DataIC50: 17nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538197(US11253521, No. 67)
Affinity DataIC50: 17.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538184(US11253521, No. 54)
Affinity DataIC50: 18.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538211(US11253521, No. 81)
Affinity DataIC50: 18.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538181(US11253521, No. 51)
Affinity DataIC50: 19.2nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538165(US11253521, No. 35)
Affinity DataIC50: 19.6nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM50157853(5-Chloro-3-hydroxy-4a,8a-dihydro-1H-quinazoline-2,...)
Affinity DataIC50: 20.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538151(US11253521, No. 21)
Affinity DataIC50: 23.8nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538161(US11253521, No. 31)
Affinity DataIC50: 24.2nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538163(US11253521, No. 33)
Affinity DataIC50: 26.1nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538164(US11253521, No. 34)
Affinity DataIC50: 26.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538192(US11253521, No. 62)
Affinity DataIC50: 28.9nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538179(US11253521, No. 49)
Affinity DataIC50: 35.4nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538156(US11253521, No. 26)
Affinity DataIC50: 37.3nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

TargetFlap endonuclease 1(Human)
Ludwig Institute For Cancer Research

US Patent
LigandPNGBDBM538166(US11253521, No. 36)
Affinity DataIC50: 42nMAssay Description:Fluorogenic biochemical assays used recombinant full-length FEN-1 or catalytic domains of Exo1, XPG or GEN1 and 200 nM of a DNA substrate (formed by ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/17/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 71 total ) | Next | Last >>
Jump to: